Skip to content
drillr.ai
Sign up

00950.HK

Lee's Pharmaceutical Holdings Limited

HKSE · Healthcare · Drug Manufacturers - Specialty & Generic · HK

HKD 1.23
−2.38%
Ask drillr

  • Aug 31, 2026, 10:02 UTC

    Lee's Pharmaceutical Holdings declared an interim dividend of HK$0.035 per share for the six months ended June 2026, up 59.1% from HK$0.022 per share in the prior-year period.

    Source:

  • Aug 27, 2026, 03:09 UTC

    Lee's Pharmaceutical Holdings issued a profit alert, expecting its interim net profit attributable to shareholders to rise 26-41% year-on-year to HK$85-95 million, driven by revenue growth and improved gross margin.

    Source:

  • Jul 30, 2026, 14:20 UTC

    Lee's Pharmaceutical's new drug clinical trial application for its proprietary ADC project ZK2401 was accepted by the Center for Drug Evaluation of China's National Medical Products Administration on 2026-07-29.

    Source: